David S Macdonald
Stock Analyst at Truist Financial
(4.88)
# 312
Out of 5,055 analysts
1152
Total ratings
64.1%
Success rate
13.4%
Average return
Main Sectors:
Stocks Rated by David S Macdonald
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMS Fresenius Medical Care AG | Reiterated: Hold | $25 → $24 | $21.54 | +11.42% | 45 | Oct 12, 2026 | |
| HUM Humana | Reiterated: Hold | $415 → $475 | $427.40 | +11.14% | 62 | Oct 12, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | n/a | $31.12 | - | 42 | Oct 6, 2026 | |
| ENSG The Ensign Group | Reiterated: Hold | n/a | $175.85 | - | 39 | Oct 5, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $350 | $289.58 | +20.86% | 44 | Oct 2, 2026 | |
| ARDT Ardent Health | Reiterated: Buy | n/a | $11.95 | - | 21 | Sep 30, 2026 | |
| PNTG The Pennant Group | Reiterated: Buy | $48 | $40.82 | +17.59% | 45 | Sep 23, 2026 | |
| DGX Quest Diagnostics | Reiterated: Hold | $250 → $260 | $233.43 | +11.38% | 44 | Sep 22, 2026 | |
| RDNT RadNet | Reiterated: Buy | $94 | $69.16 | +35.92% | 39 | Sep 22, 2026 | |
| GRDN Guardian Pharmacy Services | Reiterated: Buy | $51 | $40.58 | +25.68% | 20 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 → $365 | $317.34 | +15.02% | 35 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.25 | - | 37 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.98 | - | 24 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $12.36 | +21.36% | 36 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 | $180.70 | +18.98% | 59 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $126.56 | +18.52% | 49 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $90.39 | +30.55% | 55 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $495 | $470.44 | +5.22% | 61 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $27.06 | +3.47% | 60 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $80 | $70.16 | +14.03% | 41 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $225 | $209.19 | +7.56% | 54 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 | $271.60 | +6.77% | 70 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.25 | $2.98 | +9.06% | 58 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 → $500 | $395.62 | +26.38% | 48 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 → $475 | $428.09 | +10.96% | 33 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $37 | $37.46 | -1.23% | 15 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $120 | $131.57 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $48 | $21.67 | n/a | 6 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $87.40 | n/a | 2 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $21.02 | n/a | 1 | Oct 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €42.84 → €44.63 | €38.33 | n/a | 6 | May 2, 2019 |
Fresenius Medical Care AG
Oct 12, 2026
Reiterated: Hold
Price Target: $25 → $24
Current: $21.54
Upside: +11.42%
Humana
Oct 12, 2026
Reiterated: Hold
Price Target: $415 → $475
Current: $427.40
Upside: +11.14%
Option Care Health
Oct 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.12
Upside: -
The Ensign Group
Oct 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $175.85
Upside: -
The Cigna Group
Oct 2, 2026
Reiterated: Buy
Price Target: $350
Current: $289.58
Upside: +20.86%
Ardent Health
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.95
Upside: -
The Pennant Group
Sep 23, 2026
Reiterated: Buy
Price Target: $48
Current: $40.82
Upside: +17.59%
Quest Diagnostics
Sep 22, 2026
Reiterated: Hold
Price Target: $250 → $260
Current: $233.43
Upside: +11.38%
RadNet
Sep 22, 2026
Reiterated: Buy
Price Target: $94
Current: $69.16
Upside: +35.92%
Guardian Pharmacy Services
Sep 21, 2026
Reiterated: Buy
Price Target: $51
Current: $40.58
Upside: +25.68%
Sep 21, 2026
Reiterated: Buy
Price Target: $350 → $365
Current: $317.34
Upside: +15.02%
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.25
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $44.98
Upside: -
Aug 24, 2026
Reiterated: Hold
Price Target: $15
Current: $12.36
Upside: +21.36%
Aug 11, 2026
Reiterated: Hold
Price Target: $215
Current: $180.70
Upside: +18.98%
Aug 11, 2026
Reiterated: Buy
Price Target: $150
Current: $126.56
Upside: +18.52%
Aug 6, 2026
Reiterated: Buy
Price Target: $118
Current: $90.39
Upside: +30.55%
Aug 5, 2026
Reiterated: Buy
Price Target: $495
Current: $470.44
Upside: +5.22%
Aug 5, 2026
Reiterated: Hold
Price Target: $28
Current: $27.06
Upside: +3.47%
Jul 29, 2026
Reiterated: Buy
Price Target: $78 → $80
Current: $70.16
Upside: +14.03%
Jul 28, 2026
Reiterated: Hold
Price Target: $225
Current: $209.19
Upside: +7.56%
Jul 28, 2026
Reiterated: Buy
Price Target: $290
Current: $271.60
Upside: +6.77%
Jul 27, 2026
Reiterated: Hold
Price Target: $3.25
Current: $2.98
Upside: +9.06%
Jul 17, 2026
Reiterated: Buy
Price Target: $440 → $500
Current: $395.62
Upside: +26.38%
Jul 16, 2026
Reiterated: Buy
Price Target: $450 → $475
Current: $428.09
Upside: +10.96%
Jul 14, 2026
Reiterated: Buy
Price Target: $31 → $37
Current: $37.46
Upside: -1.23%
Apr 3, 2023
Reiterated: Hold
Price Target: $120
Current: $131.57
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $40 → $48
Current: $21.67
Upside: n/a
Jul 14, 2022
Reiterated: Buy
Price Target: $35 → $33
Current: $87.40
Upside: n/a
Oct 13, 2020
Upgraded: Hold
Price Target: n/a
Current: $21.02
Upside: n/a
May 2, 2019
Reiterated: Buy
Price Target: €42.84 → €44.63
Current: €38.33
Upside: n/a